BioSpace News Archive

On August 14, IRI’s Vijoy Gopalakrishnan will discuss the applicability and pros and cons of randomized control treatments (RCTs) in lift studies.

ClinOne has perfected the frequency and depth of content based on its platform.

Management will host a conference call the following day, Friday, August 30, 2019, at 10:00 AM Eastern Time to review the financial results.

The signing amount of the “private doctor” exceeded 300 million yuan on the first day

The SWEET study aims to enroll 3,000 participants at over 40 SWEET Study sites

Kalderos to highlight the lack of a meaningful drug discount infrastructure, which has fostered nearly $9 billion in non-compliant drug discounts in 2018 alone. [13-August-2019] CHICAGO , Aug. 13, 2019 /PRNewswire/ -- Kalderos is set to highlight the gaps and byproducts of today’s fractured drug discount system and the role technology can play in identifying and res

The second award from HRSA will enable HealthEfficient and its partners to create a Network for Oral Health Integration (NOHI) across at least 3 states and Washington, DC.

Prime Therapeutics LLC, a total drug management company serving 23 Blue Cross and Blue Shield Plans with more than 28 million members nationally, welcomed Kelly McGrail-Pokuta as its vice president of pharmacy trade relations.

Partnership to Create More Physician Access for Rural Texas Hospitals

Nephron Pharmaceuticals Corporation today announced a new partnership with InfuTronix Solutions, LLC.